Elite Pharmaceuticals Inc (ELTP)
0.5101
+0.01
(+1.75%)
USD |
OTCM |
Nov 04, 15:59
Elite Pharmaceuticals Market Cap: 544.93M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 535.58M |
| October 31, 2024 | 473.24M |
| October 30, 2024 | 464.70M |
| October 29, 2024 | 544.82M |
| October 28, 2024 | 607.85M |
| October 25, 2024 | 576.97M |
| October 24, 2024 | 614.78M |
| October 23, 2024 | 502.30M |
| October 22, 2024 | 640.96M |
| October 21, 2024 | 753.13M |
| October 18, 2024 | 624.94M |
| October 17, 2024 | 534.14M |
| October 16, 2024 | 518.11M |
| October 15, 2024 | 470.68M |
| October 14, 2024 | 446.54M |
| October 11, 2024 | 464.38M |
| October 10, 2024 | 434.15M |
| October 09, 2024 | 427.20M |
| October 08, 2024 | 430.83M |
| October 07, 2024 | 425.71M |
| October 04, 2024 | 418.44M |
| October 03, 2024 | 416.73M |
| October 02, 2024 | 448.41M |
| October 01, 2024 | 414.38M |
| September 30, 2024 | 414.49M |
| Date | Value |
|---|---|
| September 27, 2024 | 416.63M |
| September 26, 2024 | 415.50M |
| September 25, 2024 | 414.49M |
| September 24, 2024 | 404.45M |
| September 23, 2024 | 400.01M |
| September 20, 2024 | 398.44M |
| September 19, 2024 | 415.45M |
| September 18, 2024 | 413.96M |
| September 17, 2024 | 408.64M |
| September 16, 2024 | 416.41M |
| September 13, 2024 | 384.69M |
| September 12, 2024 | 429.45M |
| September 11, 2024 | 419.72M |
| September 10, 2024 | 379.02M |
| September 09, 2024 | 363.11M |
| September 06, 2024 | 334.90M |
| September 05, 2024 | 320.80M |
| September 04, 2024 | 293.78M |
| September 03, 2024 | 277.20M |
| August 30, 2024 | 295.54M |
| August 29, 2024 | 298.05M |
| August 28, 2024 | 301.68M |
| August 27, 2024 | 270.27M |
| August 26, 2024 | 255.53M |
| August 23, 2024 | 213.76M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.90M
Minimum
Dec 29 2022
753.13M
Maximum
Oct 21 2024
86.31M
Average
56.73M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.58B |
| BioCardia Inc | 5.055M |
| Zevra Therapeutics Inc | 449.36M |
| Verrica Pharmaceuticals Inc | 61.02M |
| Terns Pharmaceuticals Inc | 496.47M |
Market Cap Related Metrics
| PE Ratio | 45.30 |
| PS Ratio | 7.973 |
| PEG Ratio | 0.2836 |
| Price to Book Value | 9.355 |
| Price to Free Cash Flow | 6266.71 |
| Price | 0.5101 |
| Earnings Yield | 2.21% |
| PEGY Ratio | 0.2836 |
| Operating PE Ratio | 40.59 |
| Normalized PE Ratio | 31.70 |